This announcement is a separate document:
ステムセル研究所：「自閉症スペクトラム障害に対する自家臍帯血有核細胞を用いた治療法の開発」に関する研究者主導臨床研究契約の締結について
StemCell Institute: Conclusion of a researcher-led clinical research agreement on “development of treatment methods using autologous cord blood nucleated cells for autism spectrum disorder”
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.